Global Pharmacovigilance and Drug Safety Software Market Size Study by Functionality, by Delivery Mode (On Premise & On Demand/Cloud based), by End User & by Region - Global Forecast 2018- 2025

July 2018 | 120 pages | ID: G487D427B49EN
Bizwit Research & Consulting LLP

Abstracts

Global Pharmacovigilance and Drug Safety Software Market to reach USD 265.2 billion by 2025.

Global Pharmacovigilance and Drug Safety Software Market valued approximately USD 150.4 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6.5% over the forecast Year.The global drug safety software market is divided into two segments on the basis of delivery mode, namely, on premise delivery mode and on-demand/cloud based (SaaS) delivery mode. This market is also divided into pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers on the basis of type of end user. Factors such as increasing incidence rates of adverse drug reactions (ADRs) and growing adoption of pharmacovigilance software by organizations such as CROs and BPOs are driving the growth of the global pharmacovigilance software market.

Manufacturers are now striving to identify various ways of cost reduction and minimizing operational expenses by gradually shifting from being fully integrated pharmaceutical companies to sharing costs by collaborating with service providers. Outsourcing helps increase internal resource flexibility, improves timelines, and results in better outcomes in short as well as long terms. Outsourcing also helps achieve better pharmacovigilance (PV) through regulatory compliance, higher quality, better productivity, and improved strategic outcomes. PV service providers, in an attempt to ensure sustainability, are providing customized and end-to-end solutions to meet consumer needs.

The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Functionality:

• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software
• Fully Integrated Software

By Delivery Mode:

• On-Premise
• On-Demand/Cloud Based

By End User:

• Pharma and Biotech Companies
• Contract Research Organizations (CROS)
• Business Process Outsourcing (BPO) Firms

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Mexico
• Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are- ArisGlobal, GMBH., Ennov., Oracle Corporation, Online Business Applications, Inc, Sarjen Systems Pvt. Ltd, Sparta Systems, Inc, United Bio source Corporation, Umbra Global & AB -Cube. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Pharmacovigilance and Drug Safety Software Market In Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET DEFINITION AND SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY FUNCTIONALITY

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Pharmacovigilance and Drug Safety Software Market, Sub Segment Analysis
  5.3.1. Adverse Event Reporting Software
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.2. Drug Safety Audits Software
    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.3. Issue Tracking Software
    5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.4. Fully Integrated Software
    5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY DELIVERY MODE

6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Pharmacovigilance and Drug Safety Software Market, Sub Segment Analysis
  6.3.1. On Premise
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.2. On Demand / Cloud based
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY END USER

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Pharmacovigilance and Drug Safety Software Market, Sub Segment Analysis
  7.3.1. Pharma and Biotech Companies
    7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.2. Contract Research Organizations (CROS)
    7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.3. Business Process Outsourcing (BPO) Firms
    7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY REGIONAL ANALYSIS

8.1. Global Pharmacovigilance and Drug Safety Software Market, Regional Market Snapshot (2015-2025)
8.2. North America Global Pharmacovigilance and Drug Safety Software Market Snapshot
  8.2.1. U.S.
    8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
  8.2.2. Canada
    8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
8.3. Europe Global Pharmacovigilance and Drug Safety Software Market Snapshot
  8.3.1. U.K.
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
  8.3.2. Germany
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
  8.3.3. France
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
  8.3.4. Rest of Europe
    8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
8.4. Asia Global Pharmacovigilance and Drug Safety Software Market Snapshot
    8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
  8.4.2. India
    8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
  8.4.3. Japan
    8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
  8.4.4. Rest of Asia Pacific
    8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
8.5. Latin America Global Pharmacovigilance and Drug Safety Software Market Snapshot
  8.5.1. Brazil
    8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
  8.5.2. Mexico
    8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
  8.5.3. Rest of The World
  8.5.4. South America
    8.5.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.4.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.4.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.4.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)
  8.5.5. Middle East and Africa
    8.5.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.5.2. Functionality breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.5.3. Delivery Mode breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.5.4. End User breakdown estimates & forecasts, 2015-2025 (USD billion)

CHAPTER 9. COMPANY PROFILES

9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
  9.3.1. AB-Cube
    9.3.1.1. Overview
    9.3.1.2. Financial (Subject to Data Availability)
    9.3.1.3. Product Summary
    9.3.1.4. Recent Developments
  9.3.2. ArisGlobal
  9.3.3. Extedo GMBH.
  9.3.4. Ennov.
  9.3.5. Oracle Corporation
  9.3.6. Online Business Applications, Inc
  9.3.7. Sarjen Systems Pvt. Ltd
  9.3.8. Sparta Systems, Inc
  9.3.9. United Biosource Corporation
  9.3.10. Umbra Global